Fig. 7: Viability of inhibitors and chemotherapy treated K562 cells.

Average viability with standard deviation of inhibitors and chemotherapy-treated K562 cells after (N = 3), with p-values are calculated with respect to only daunorubicin-treated cells in which * represents p < 0.05 and ** represents p < 0.0005